会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PREDICTION OF LIPID-METABOTYPE-RELATED PHYSIOLOGICAL SUSCEPTIBILITIES
    • 脂肪代谢相关生理学可能性的预测
    • WO2010060996A3
    • 2010-08-12
    • PCT/EP2009066003
    • 2009-11-27
    • HELMHOLTZ ZENTRUM MUENCHENSUHRE KARSTENGIEGER CHRISTIAN
    • SUHRE KARSTENGIEGER CHRISTIAN
    • C12Q1/68
    • C12Q1/6883C12Q2600/156C12Q2600/172
    • The present invention relates to a method for determining a predisposition of a human subject for physiological susceptibilities that result from alterations in lipid metabolism, wherein the physiological susceptibilities are selected from sensitivity to functional food, physical health schemes, identification of non-responsiveness to treatment by diet or physical activity. The present invention further relates to a method for determining a predisposition of a human subject for physiological susceptibilities that result from alterations in lipid metabolism, wherein the physiological susceptibilities are selected from sensitivity to drug treatment or identification of non- responsiveness to treatment by medication. The methods of the present invention comprise determining, in a sample obtained from the human subject, the genotype of that person with respect to at least two genetic polymorphisms selected from the group consisting of a) rs2014355; b) rs11161510; c) rs2286963; d) rs174548; e) rs9393903; f) rs168622; g) rs541503; h) rs2046813; i) rs272889; j) rs2216405; k) rs7156144; l) rs8396; m) rs7094971; and n) rs603424; wherein the presence of one or two copies of the minor allele of at least two genetic polymorphisms is indicative of a predisposition for said physiological susceptibilities. The polymorphisms listed above are located in the following genes: SCAD, MCAD, LCAD, FADS1, EL0VL2, SPTLC3, PHGDH, ACSL1, OCTN1, CPS1, PLEKHH1, ETFDH, SLC16A9 and SCD.
    • 本发明涉及一种用于确定人类受试者对由脂质代谢改变引起的生理敏感性的易感性的方法,其中所述生理敏感性选自对功能性食物的敏感性,身体健康方案,对对治疗的无反应性的鉴定 饮食或身体活动。 本发明还涉及一种用于确定人类受试者对由脂质代谢改变引起的生理敏感性的倾向的方法,其中所述生理敏感性选自药物治疗的敏感性或通过药物治疗的不敏感性。 本发明的方法包括在从人受试者获得的样品中确定该人对于至少两种选自以下的遗传多态性的基因型:a)rs2014355; b)rs11161510; c)rs2286963; d)rs174548; e)rs9393903; f)rs168622; g)rs541503; h)rs2046813; i)rs272889; j)rs2216405; k)rs7156144; l)rs8396; m)rs7094971; 和n)rs603424; 其中至少两个遗传多态性的次要等位基因的一个或两个拷贝的存在表示所述生理敏感性的易感性。 以上列出的多态性位于以下基因:SCAD,MCAD,LCAD,FADS1,EL0VL2,SPTLC3,PHGDH,ACSL1,OCTN1,CPS1,PLEKHH1,ETFDH,SLC16A9和SCD。